More than 18,000 employees at Gilead worldwide work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work.

What is bearingmath

For more than 35 years, we’ve been tackling some of the world’s greatest public health challenges, revolutionizing HIV treatment and prevention and delivering a cure for hepatitis C. Now, we're working to discover and advance therapies that offer new hope to patients impacted by diseases across our therapeutic areas of Virology, Oncology and Inflammation.

This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit our Global Operations page for links to our international corporate websites.